Emergent Biosolutions Inc (NYSE: EBS) kicked off on Tuesday, up 4.01% from the previous trading day, before settling in for the closing price of $6.49. Over the past 52 weeks, EBS has traded in a range of $4.02-$15.10.
Here's Your FREE Report on the #1 Small-Cap Uranium Stock of '24.
Small-cap Uranium stocks are booming in 2024! The company we're about to show you is the ONLY small-cap stock in the space that benefits from ALL aspects of the global Uranium industry with none of the risks of running a mine. Smart investors will not be hesitating on this one!
Get the FREE Report with all the details here.
Sponsored
Over the past five-year period, the drop rate of yearbook sales for the company of the Healthcare sector was -1.15%. While this was happening, its average annual earnings per share was recorded 469.57%. With a float of $51.91 million, this company’s outstanding shares have now reached $54.50 million.
Considering the fact that the conglomerate employs 900 people, you should pay attention to its efficiency factor. In terms of profitability, gross margin is 31.6%, operating margin of -5.65%, and the pretax margin is -6.49%.
Emergent Biosolutions Inc (EBS) Insider Activity
Our next focus will be how large-scale investors are participating in this stock of the Drug Manufacturers – Specialty & Generic Industry. The insider ownership of Emergent Biosolutions Inc is 4.36%, while institutional ownership is 66.76%. The most recent insider transaction that took place on May 23 ’25, was worth 49,417. In this transaction Director of this company sold 7,844 shares at a rate of $6.30, taking the stock ownership to the 86,431 shares. Before that another transaction happened on May 23 ’25, when Company’s Director proposed sale 7,844 for $6.30, making the entire transaction worth $49,409.
Emergent Biosolutions Inc (EBS) Earnings and Forecasts
According to the Wall Street analysts, stocks earnings will be around 469.57% per share during the next fiscal year.
Emergent Biosolutions Inc (NYSE: EBS) Trading Performance Indicators
Take a look at Emergent Biosolutions Inc’s (EBS) current performance indicators. Last quarter, stock had a quick ratio of 3.51. In addition, a publicly-traded company’s price to sales ratio for the trailing twelve months stands at 0.38. Likewise, its price to free cash flow for the trailing twelve months is 3.88.
For the trailing twelve months, Company’s Diluted EPS (Earnings per Share) is -2.71, a number that is poised to hit -0.10 in the next quarter and is forecasted to reach 1.25 in one year’s time.
Technical Analysis of Emergent Biosolutions Inc (EBS)
Compared to the last year’s volume of 1.2 million, its volume of 0.93 million showed lagged in the last five days. As of the previous 9 days, the stock’s Stochastic %D was 77.59%. Additionally, its Average True Range was 0.42.
During the past 100 days, Emergent Biosolutions Inc’s (EBS) raw stochastic average was set at 34.30%, which indicates a significant decrease from 78.72% during the past two weeks. Based on volatility metrics of the stock, it showed a historical volatility of 60.71% in the past 14 days, which was lower than the 93.42% volatility it showed in the past 100 days.
At the time of writing, stock’s 50-day Moving Average is $5.51, while its 200-day Moving Average is $7.81.
